1 / 2Opioid Lawsuit OklahomaFILE - In this July 15, 2019, file photo, Oklahoma Attorney General Mike Hunter speaks during closing arguments in Oklahoma's ongoing opioid drug lawsuit against Johnson & Johnson, in Norman, Okla. An Oklahoma judge is expected to deliver a judgment following a first-of-its-kind trial in which the state is trying to hold an opioid drugmaker responsible for the devastating consequences of addiction to the powerful painkillers. NORMAN, Okla.
"The opioid crisis has ravaged the state of Oklahoma," Balkman said before announcing the verdict."It must be abated immediately."Before Oklahoma's trial began May 28, Oklahoma reached settlements with two other defendant groups — a $270 million deal with OxyContin-maker Purdue Pharma and an $85 million settlement with Israeli-owned Teva Pharmaceutical Industries Ltd.
Mike Hunter has called Johnson & Johnson a "kingpin" company that was motivated by greed. He specifically pointed to two former Johnson & Johnson subsidiaries, Noramco and Tasmanian Alkaloids, which produced much of the raw opium used by other manufacturers to produce the drugs. Attorneys for the company have maintained they were part of a lawful and heavily regulated industry subject to strict federal oversight, including the U.S. Drug Enforcement Agency and the Food and Drug Administration, during every step of the supply chain. Lead attorney Larry Ottaway said during closing arguments that opioid drugs serve a critical health need — to address chronic pain that affects thousands of Oklahomans every day.
572M for them is peanuts.
Ibogaine? IV Ketamine coma trials to cure pathological pain?
How they do that
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Reuters - 🏆 2. / 97 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: CNN - 🏆 4. / 95 Read more »
Source: AP - 🏆 728. / 51 Read more »
Source: NBCNews - 🏆 10. / 86 Read more »
Source: Reuters - 🏆 2. / 97 Read more »